TWITTER

• Why did ADC Therapeutics and Shanghai Miracogen expand their ADC licensing deals with Synaffix to develop additiona… https://t.co/UkCiXcx6CA 5 days ago
• Miracogen has expanded our collaboration to a 2nd program, representing the 6th ADC being developed by our partners… https://t.co/hZSfWT2Jt7 2 weeks ago